Mario Giuliani

Directeur/Membre du Conseil chez HBM HEALTHCARE INVESTMENTS AG

Fortune : 41 M $ au 31/05/2026

54 ans

18 relations

Health Technology

Finance

Miscellaneous

Profil

Currently, Mario Germano Giuliani is Co-Managing Director at MIKA Pharma GmbH; Director at GISEV Family Office SA since 2023; Director at Nogra Pharma Invest SARL; Director at MGG Capital SAM since 2015; Director at Giuliani Group SpA; President & Director at MGG Strategic SICAF SIF SA since 2022; Director at ElevateBio LLC since 2020; Director at NGR Luxembourg SA; Director at GISEV Group Lux SA; and Director at Nogra Real Estate SARL. Formerly, Dr. Giuliani was Chairman, Chief Executive & Financial Officer at Giuliani SpA from 1996 to 2014; Director at Nogra Group SA from 2015 to 2016; Director at Fair-Med Healthcare AG from 2013 to 2017; Director at Nogra Private Equity SARL; Director at Jukka LLC from 2015 to 2019; Independent Non-Executive Director at Recordati SpA from 2011 to 2014; Director at Nogra Pharma Ltd.; Independent Director at Royalty Pharma Plc from 2020 to 2024; and Principal at Mosaix Ventures LLC from 2000 to 2010.
Education includes undergraduate studies at Università Cattolica del Sacro Cuore Campus di Milano.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
RPI International Holdings 2019 LP RPI International Holdings 2019 LP Financial ConglomeratesFinance Functions as an investment fund 2,63 %	18/06/2020	728 320 ( 2,63 % )	41 M $	31/05/2026

Postes actifs de Mario Giuliani

Sociétés	Poste	Début
HBM HEALTHCARE INVESTMENTS AG	Directeur/Membre du Conseil	01/01/2012
GISEV Group Lux SA GISEV Group Lux SA Financial ConglomeratesFinance Functions as an investment holding company	Directeur/Membre du Conseil	-
MGG Strategic SICAF SIF SA MGG Strategic SICAF SIF SA Investment Trusts/Mutual FundsMiscellaneous Functions as an open-end investment fund	President	01/01/2022
Nogra Pharma Invest SARL	Directeur/Membre du Conseil	-
MIKA Pharma GmbH MIKA Pharma GmbH Pharmaceuticals: MajorHealth Technology Develops and produces dermal, transdermal and buccal application systems	Directeur Général	-
Nogra Real Estate SARL	Directeur/Membre du Conseil	-
Giuliani Group SpA Giuliani Group SpA Financial ConglomeratesFinance Functions as an investment holding company	Directeur/Membre du Conseil	-
NGR Luxembourg SA	Directeur/Membre du Conseil	-
MGG Capital SAM MGG Capital SAM Financial ConglomeratesFinance Operates as an investment company	Directeur/Membre du Conseil	01/01/2015
░░░░░░░░░░ ░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░

Tous les postes actifs de Mario Giuliani

Anciens postes connus de Mario Giuliani

Sociétés	Poste	Fin
░░░░░░░ ░░░░░░ ░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░ ░░░░░░░ ░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░ ░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░ ░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░ ░░░░░ ░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░

Voir l'expérience en détail de Mario Giuliani

Formation de Mario Giuliani

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Mario Giuliani

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	21
Recordati SpA Recordati SpA Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products	Health Technology
Mosaix Ventures LLC Mosaix Ventures LLC Investment ManagersFinance Mosaix Ventures invests in companies located in the United States. The firm targets companies operating in the fields of medical devices and technology-enabled service sectors. It provides financing for later, recapitalization and growth stage capital requirements with an investment size of USD 1 - 5 million for venture stage deals and USD 10 - 20 million for growth equity and recapitalizations.	Finance
HBM Healthcare Investments AG HBM Healthcare Investments AG Investment Trusts/Mutual FundsMiscellaneous Functions as a closed-end investment fund or Investment trust	Miscellaneous
Università Cattolica del Sacro Cuore Campus di Milano Università Cattolica del Sacro Cuore Campus di Milano Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
MIKA Pharma GmbH MIKA Pharma GmbH Pharmaceuticals: MajorHealth Technology Develops and produces dermal, transdermal and buccal application systems	Health Technology
Giuliani SpA Giuliani SpA Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets medicines, medical devices, dermo cosmetic products & food supplements	Health Technology
Nogra Pharma Ltd. Nogra Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Nogra Pharma Invest SARL
Giuliani Group SpA Giuliani Group SpA Financial ConglomeratesFinance Functions as an investment holding company	Finance
Fair-Med Healthcare AG Fair-Med Healthcare AG Pharmaceuticals: OtherHealth Technology Manufactures generic medicines	Health Technology
ElevateBio LLC ElevateBio LLC BiotechnologyHealth Technology Operates as biotechnology holding company, which develops gene therapy and manufactures & commercializes life-transforming medicines	Health Technology
GISEV Family Office SA GISEV Family Office SA Investment ManagersFinance Provides fund management and accounting services	Finance
Royalty Pharma Plc Royalty Pharma Plc Pharmaceuticals: MajorHealth Technology Buys and operates a portfolio of biopharmaceutical royalties	Health Technology
MGG Capital SAM MGG Capital SAM Financial ConglomeratesFinance Operates as an investment company	Finance
Jukka LLC
NGR Luxembourg SA
GISEV Group Lux SA GISEV Group Lux SA Financial ConglomeratesFinance Functions as an investment holding company	Finance
Nogra Private Equity SARL
Nogra Real Estate SARL
Nogra Group SA
MGG Strategic SICAF SIF SA MGG Strategic SICAF SIF SA Investment Trusts/Mutual FundsMiscellaneous Functions as an open-end investment fund	Miscellaneous